Cyclobarbital
Cyclobarbital, also known as cyclobarbitol or cyclobarbitone, is a drug that is a barbiturate derivative.[1] It is primarily available in fixed-dose combination with diazepam under the brand name Reladorm (100 mg cyclobarbital + 10 mg diazepam) and is used to treat insomnia in Russia.[2]
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral (tablets) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.127 |
Chemical and physical data | |
Formula | C12H16N2O3 |
Molar mass | 236.271 g·mol−1 |
3D model (JSmol) | |
| |
| |
|
References
- Breimer DD, Winten MA (March 1976). "Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration". European Journal of Clinical Pharmacology. 09 (5–6): 443–50. doi:10.1007/bf00606563. PMID 989475.
- "Russian State Register of Medicines. Registration Certificate: Reladorm (diazepam + cyclobarbital). Revised 02 Sep 2013" (in Russian). Retrieved 6 March 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.